Tag - AMD

Developments

LumiThera enrolls first patient in U.S. multi-center trial in dry AMD

Closely-held LumiThera enrolled the first patient in its multi-center U.S. clinical trial in patients with dry age-related macular degeneration (AMD). The study, called LIGHTSITE III, will evaluate LumiThera’s Valeda...

October 1, 2019

Developments

Outlook Therapeutics completes enrollment in Phase 3 wet AMD trial

Outlook Therapeutics (NASDAQ:OTLK) completed patient enrollment in its Phase 3 clinical trial comparing ONS-5010 to ranibizumab for the treatment of wet age-related macular degeneration (AMD). Administered via...

August 20, 2019

Feature

Ocutrx augmented reality headset helping AMD patients see clearly

California-based Ocutrx Vision Technologies has developed an augmented reality (AR) headset that helps age-related macular degeneration (AMD) patients overcome severe and devastating vision loss.

July 9, 2019

Tag - AMD

LumiThera enrolls first patient in U.S. multi-center trial in dry AMD

Ocutrx augmented reality headset helping AMD patients see clearly

General

More